Robyn H Guymer
Guymer, Robyn H.
Guymer, Robyn
VIAF ID: 215153409761041582045 (Personal)
Permalink: http://viaf.org/viaf/215153409761041582045
Preferred Forms
- 100 1 _ ‡a Guymer, Robyn
- 100 1 _ ‡a Guymer, Robyn H.
- 100 0 _ ‡a Robyn H Guymer
4xx's: Alternate Name Forms (2)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
The longitudinal impact of macular telangiectasia (MacTel) type 2 on vision-related quality of life. | |
Marked discordance for myopia in female monozygotic twins. | |
Nanosecond-laser application in intermediate AMD: 12-month results of fundus appearance and macular function | |
Nanosecond laser therapy reverses pathologic and molecular changes in age-related macular degeneration without retinal damage. | |
New Treatment Modalities for Geographic Atrophy. | |
Non-mydriatic digital macular photography: how good is the second eye photograph? | |
Optical Coherence Tomography-Guided Retinal Prosthesis Design: Model of Degenerated Retinal Curvature and Thickness for Patient-Specific Devices | |
Perifoveal müller cell depletion in a case of macular telangiectasia type 2. | |
PERIPHERAL RETINAL DRUSEN–LIKE DEPOSITS IN GUCY2C CONGENITAL SECRETORY DIARRHEA SYNDROME | |
Photodynamic therapy in practice: a review of the results of the first 12 months experience with verteporfin at the Royal Victorian Eye and Ear Hospital. | |
Plasma levels of amyloid beta and other proinflammatory mediators in patients with age-related macular degeneration | |
Predictors of AMD Treatment Response | |
The prevalence estimates of macular telangiectasia type 2: the Melbourne Collaborative Cohort Study. | |
Progress in the clinical development and utilization of vision prostheses: an update | |
Proof of concept, randomized, placebo-controlled study of the effect of simvastatin on the course of age-related macular degeneration | |
Prophylactic laser treatment hastens choroidal neovascularization in unilateral age-related maculopathy: final results of the drusen laser study | |
Prophylactic laser treatment to fellow eyes of unilateral retinal pigment epithelial tears. | |
Quantitative Analysis of the Ellipsoid Zone Intensity in Phenotypic Variations of Intermediate Age-Related Macular Degeneration. | |
Rasch Analysis of the Independent Mobility Questionnaire. | |
Recurrent structural variation, clustered sites of selection, and disease risk for the complement factor H (CFH) gene family. | |
Refractive errors in twin studies | |
Relationship Between the Second Reflective Band on Optical Coherence Tomography and Multifocal Electroretinography in Age-Related Macular Degeneration | |
Repeatability of Retinal Sensitivity Measurements Using a Medmont Dark-Adapted Chromatic Perimeter in Healthy and Age-Related Macular Degeneration Cases. | |
Reply | |
Restorative retinal laser therapy: Present state and future directions | |
Reticular pseudodrusen: a risk factor for geographic atrophy in fellow eyes of individuals with unilateral choroidal neovascularization. | |
Reticular Pseudodrusen in Intermediate Age-Related Macular Degeneration: Prevalence, Detection, Clinical, Environmental, and Genetic Associations | |
Retinal venular caliber predicts visual outcome after intravitreal ranibizumab injection treatments for neovascular AMD. | |
Role of Flicker Perimetry in Predicting Onset of Late-Stage Age-Related Macular Degeneration | |
Role of genetic factors in lower- and higher-order aberrations--the genes in myopia twin study. | |
Role of lysophosphatidic acid in the retinal pigment epithelium and photoreceptors. | |
Safety and efficacy of a flexible dosing regimen of ranibizumab in neovascular age-related macular degeneration: the SUSTAIN study | |
Scheduled versus Pro Re Nata Dosing in the VIEW Trials. | |
Serine and Lipid Metabolism in Macular Disease and Peripheral Neuropathy | |
A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy | |
Sorsby's Fundus Dystrophy: a case report to raise awareness of the disease and potential future treatments. | |
Splitting the Lumps: The Importance of Phenotyping Drusen | |
Stimulation of a Suprachoroidal Retinal Prosthesis Drives Cortical Responses in a Feline Model of Retinal Degeneration | |
Survival Bias When Assessing Risk Factors for Age-Related Macular Degeneration: A Tutorial with Application to the Exposure of Smoking. | |
Systemic lipid dysregulation is a risk factor for macular neurodegenerative disease | |
Temporal sensitivity deficits in patients with high-risk drusen | |
Test-Retest Repeatability of Microperimetry at the Border of Deep Scotomas | |
Testing Protocol and Recruitment in the Genes in Myopia Twin Study | |
Therapeutic targeting of the complement system in age-related macular degeneration: a review. | |
Time to initial clinician-reported inactivation of neovascular age-related macular degeneration treated primarily with ranibizumab | |
Urocanic acid as an immunosuppressant in allotransplantation in mice | |
Variants in the VEGFA gene and treatment outcome after anti-VEGF treatment for neovascular age-related macular degeneration. | |
Variation of Codons 1961 and 2177 of the Stargardt Disease Gene Is Not Associated With Age-Related Macular Degeneration | |
Variations in apolipoprotein E frequency with age in a pooled analysis of a large group of older people | |
Visual Function Decline Resulting from Geographic Atrophy: Results from the Chroma and Spectri Phase 3 Trials | |
Visual impairment as a function of visual acuity in both eyes and its impact on patient reported preferences | |
Visual impairment caused by retinal abnormalities in mesangiocapillary (membranoproliferative) glomerulonephritis type II ("dense deposit disease") | |
Younger Siblings, C-Reactive Protein, and Risk of Age-Related Macular Degeneration | |
প্রত্যুত্তর |